The Roles of CD8(+) and CD4(+) Cells in Tumor Rejection

In vivo administrations of anti‐Lyt‐2.2 (CDS) mAb and anti‐L3T4 (CD4) mAb selectively eliminated CD8(+) cells amd CD4(+) cells, respectively. The relative potencies of CD8(+) cells and CD4(+) cells and their roles in primary tumor rejections were studied by investigating the effects of these mAbs on...

Descripción completa

Detalles Bibliográficos
Autores principales: Udono, Heiichiro, Mieno, Masahiro, Shiku, Hiroshi, Nakayama, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1989
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917808/
https://www.ncbi.nlm.nih.gov/pubmed/2571603
http://dx.doi.org/10.1111/j.1349-7006.1989.tb01692.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917808/
https://www.ncbi.nlm.nih.gov/pubmed/2571603
http://dx.doi.org/10.1111/j.1349-7006.1989.tb01692.x

Ejemplares similares